07.09.2018 Views

blood group typing market

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

RESEARCH REPORT<br />

MARCH - 2018<br />

GLOBAL BLOOD GROUP TYPING MARKET<br />

BY PRODUCT TYPE, SIZE, SHARE, GROWTH, TRENDS AND FORECASTS 2017-2022


Global Rubella Vaccine Market<br />

The global Blood Group Typing <strong>market</strong> is anticipated to grow at 9.80% CAGR from 2017<br />

to 2022 and it is estimated that the global <strong>market</strong> was valued at USD 2.15 billion in 2017<br />

and is expected to reach USD 3.43 billion by 2022.<br />

Classification of <strong>blood</strong> on the basis of absence and presence of antibodies or inherited<br />

antigenic substances on the surface of red <strong>blood</strong> cells is termed as <strong>blood</strong> <strong>group</strong> <strong>typing</strong>.<br />

These antigens may be proteins, carbohydrates, glycoproteins, or glycolipids, depending<br />

on the <strong>blood</strong> <strong>group</strong> system. Some of these antigens are present on the surface of other<br />

types of cells of various tissues. Several of these red <strong>blood</strong> cell surface antigens can<br />

stem from one allele and collectively form a <strong>blood</strong> <strong>group</strong> system.<br />

The global <strong>market</strong> for molecular <strong>blood</strong> <strong>group</strong>ing is increasing significantly. The <strong>market</strong><br />

has a lot of potential due to a growth in the demand for <strong>blood</strong> transfusion. For the<br />

purpose of transfusion, donor <strong>blood</strong> compatibility with recipient patient is highly<br />

important. Therefore, before transfusion of <strong>blood</strong>, in order to check compatibility, <strong>blood</strong><br />

samples are cross-matched with each other. Transfusion of <strong>blood</strong> is usually safe;<br />

however, alloimmunization can create a complication in the recipient. The<br />

alloimmunization can be dreadful in patients’ suffering from diseases like sickle cell<br />

anemia. The molecular <strong>blood</strong> <strong>group</strong> <strong>typing</strong> is used to determine the presence of antigens<br />

in the red <strong>blood</strong> cells through testing. In general, A, B, and D (Rh) antigens are tested as<br />

part of standard procedure, followed by determination of other antigens if required.<br />

Reverse <strong>group</strong>ing confirms ABO <strong>blood</strong> <strong>group</strong> <strong>typing</strong> by detecting expected isoagglutinins.<br />

The varying use of <strong>blood</strong> <strong>typing</strong> and <strong>group</strong>ing test in research activities and<br />

transfusion procedures has upsurge the molecular <strong>blood</strong> <strong>typing</strong>, <strong>group</strong>ing and infectious<br />

disease nucleic acid testing <strong>market</strong>. Factors such as the increased government<br />

interventions and growing demand have increased the <strong>market</strong> for molecular <strong>blood</strong><br />

<strong>typing</strong>, <strong>group</strong>ing, and infectious disease NAT. However, restraining factors like<br />

administrative and logistical challenges, slow turnaround, high cost, the requirement of<br />

high-end equipment and inadequate information systems for handling the results. Owing<br />

to these facts, the <strong>market</strong> observes a rise in the demand for molecular <strong>typing</strong> tests. The<br />

adoption of molecular testing in <strong>blood</strong> transfusion procedures has mitigated the<br />

challenges faced to a significant extent.<br />

The global Blood Group Typing Market is segmented on the basis of Technique,<br />

Product, Test Type, and End User. On the basis of Product, the <strong>market</strong> is segmented<br />

into Consumable, Instrument, and Service. Consumables segment is further segmented<br />

into anti-human globulin reagents, red <strong>blood</strong> cells reagents, antisera reagents, and <strong>blood</strong><br />

bank saline. Consumables segment is expected to grow at the highest CAGR during the<br />

forecast period. The sudden rise in <strong>blood</strong> donation rates is another key factor driving the<br />

growth of this segment. On the basis of Test Type, the <strong>market</strong> is segmented into<br />

prestige ABO, Antigen, Antibody Screening, Cross Matching, and HLA. The antibody<br />

screening segment is projected to witness the highest CAGR in this <strong>market</strong> segment in<br />

the coming years due to the increasing prevalence of chronic disorders and growing<br />

demand for the early diagnosis of diseases. On the basis of Technique, the <strong>market</strong> is<br />

segmented into Assay, PCR, Microarray, and Massively Parallel Sequencing. The PCRbased<br />

and microarray techniques segment accounted for the largest share of this <strong>market</strong><br />

segment and is further expected to grow at the highest CAGR during the forecast period<br />

due to the rising prevalence of chronic diseases and increasing R&D activities focused<br />

on understanding the molecular basis of <strong>blood</strong> and antibody-antigen interactions. On the<br />

basis of End User, the <strong>market</strong> is segmented into Clinical Laboratories, Blood Banks,<br />

Hospitals, and Other End Users. The hospitals end-user segment is expected to grow at<br />

the highest CAGR during the forecast period owing to an increase in the awareness<br />

+1 888-702-9626 | www.<strong>market</strong>dataforecast.com | contact@<strong>market</strong>dataforecast.com


Global Rubella Vaccine Market<br />

among people regarding <strong>blood</strong> donations and its importance, rising number of <strong>blood</strong><br />

donations, and growing requirement of <strong>blood</strong> in surgical treatments.<br />

On the basis of geography, the Blood Group Typing <strong>market</strong> is segmented into North<br />

America, Europe, Asia Pacific, Latin America and Middle East and Africa. North America<br />

occupies the largest <strong>market</strong> share followed by Europe. The United States has been the<br />

major <strong>market</strong> across the world. Factors such as advanced technology, research, and<br />

development activities have boosted the North America <strong>market</strong>. Asia Pacific is expected<br />

to witness the highest CAGR during the forecast period due to the rising population, and<br />

an increase in disposable income. Furthermore, due to these factors, the Asian <strong>market</strong> is<br />

observing a high number of new entrants compared to those in developed regions.<br />

The <strong>market</strong> is dominated by companies like Bio-Rad Laboratories, Inc., Grifols, S.A.,<br />

Immucor Inc., Ortho Clinical Diagnostics, Inc., Quotient, Ltd., Novacyt Group, BAG<br />

Healthcare GmbH, Rapid Labs, Day medical SA, DIAGAST, and AXO Science.<br />

.TABLE OF CONTENT<br />

1. Introduction<br />

1.1 Market Definition<br />

1.2 Study Deliverables<br />

1.3 Base Currency, Base Year and Forecast Periods<br />

1.4 General Study Assumptions<br />

2. Research Methodology<br />

3. Overview<br />

2.1 Introduction<br />

2.2 Research Phases<br />

2.2.1 Secondary Research<br />

2.2.2 Primary Research<br />

2.2.3 Econometric Modelling<br />

2.2.4 Expert Validation<br />

2.3 Analysis Design<br />

2.4 Study Timeline<br />

3.1 Executive Summary<br />

3.2 Key Inferences<br />

3.3 Epidemology<br />

4. Drivers, Restraints, Opportunities, and Challenges Analysis<br />

(DROC)<br />

4.1 Market Drivers<br />

4.2 Market Restraints<br />

+1 888-702-9626 | www.<strong>market</strong>dataforecast.com | contact@<strong>market</strong>dataforecast.com


Global Rubella Vaccine Market<br />

4.3 Key Challenges<br />

4.4 Current Opportunities in the Market<br />

5. Market Segmentation<br />

5.1 Product<br />

5.2 Test Type<br />

5.1.1 Introduction<br />

5.1.2 Consumables<br />

5.1.3 Instrument<br />

5.1.4 Services<br />

5.1.2.1 Antisera Reagents<br />

5.1.2.2 Red Blood Cell Reagents<br />

5.1.2.3 Anti-Human Globulin Reagents<br />

5.1.2.4 Blood Bank Saline<br />

5.1.5 Y-o-Y Growth Analysis, By Product<br />

5.1.6 Market Attractiveness Analysis, By Product<br />

5.1.7 Market Share Analysis, By Product<br />

5.2.1 Introduction<br />

5.2.2 ABO<br />

5.2.3 Antigen<br />

5.2.4 Antibody Screening<br />

5.2.5 Cross Matching<br />

5.2.6 HLA<br />

5.2.7 Y-o-Y Growth Analysis, By Test Type<br />

5.2.8 Market Attractiveness Analysis, By Test Type<br />

5.2.9 Market Share Analysis, By Test Type<br />

Browse full report @ https://www.<strong>market</strong>dataforecast.com/<strong>market</strong>-reports/<strong>blood</strong>-<strong>group</strong><strong>typing</strong>-<strong>market</strong>-6350/<br />

5.3 Technique<br />

5.3.1 Introduction<br />

5.3.2 Assay<br />

5.3.3 PCR<br />

5.3.4 Microarray<br />

5.3.5 Massively Parallel Sequencing<br />

+1 888-702-9626 | www.<strong>market</strong>dataforecast.com | contact@<strong>market</strong>dataforecast.com


Global Rubella Vaccine Market<br />

5.3.6 Y-o-Y Growth Analysis, By Technique<br />

5.3.7 Market Attractiveness Analysis, By Technique<br />

5.3.8 Market Share Analysis, By Technique<br />

Request sample report @ https://www.<strong>market</strong>dataforecast.com/<strong>market</strong>-reports/<strong>blood</strong><strong>group</strong>-<strong>typing</strong>-<strong>market</strong>-6350/request-sample<br />

5.4 End User<br />

5.4.1 Introduction<br />

5.4.2 Hospitals<br />

5.4.3 Clinical Laboratories<br />

5.4.4 Blood Banks<br />

5.4.5 Other End Users<br />

5.4.6 Y-o-Y Growth Analysis, By End User<br />

5.4.7 Market Attractiveness Analysis, By End User<br />

5.4.8 Market Share Analysis, By End User<br />

Inquire before buying @ https://www.<strong>market</strong>dataforecast.com/<strong>market</strong>-reports/<strong>blood</strong><strong>group</strong>-<strong>typing</strong>-<strong>market</strong>-6350/inquire<br />

6. Geographical Analysis<br />

6.1 Introduction<br />

6.1.1 Regional Trends<br />

6.1.2 Impact Analysis<br />

6.1.3 Y-o-Y Growth Analysis<br />

6.1.3.1 By Geographical Area<br />

6.1.3.2 By Product<br />

6.1.3.3 By Test Type<br />

6.1.3.4 By Technique<br />

6.1.3.5 By End User<br />

Request discount @ https://www.<strong>market</strong>dataforecast.com/<strong>market</strong>-reports/<strong>blood</strong>-<strong>group</strong><strong>typing</strong>-<strong>market</strong>-6350/request-discount<br />

6.1.4 Market Attractiveness Analysis<br />

6.1.4.1 By Geographical Area<br />

6.1.4.2 By Product<br />

6.1.4.3 By Test Type<br />

6.1.4.4 By Technique<br />

6.1.4.5 By End User<br />

+1 888-702-9626 | www.<strong>market</strong>dataforecast.com | contact@<strong>market</strong>dataforecast.com


Global Rubella Vaccine Market<br />

6.2 North America<br />

6.1.5 Market Share Analysis<br />

6.1.1 Introduction<br />

6.1.5.1 By Geographical Area<br />

6.1.5.2 By Product<br />

6.1.2 United States<br />

6.1.3 Canada<br />

6.1.5.3 By Test Type<br />

6.1.5.4 By Technique<br />

6.1.5.5 By End User<br />

Buy full report @ https://www.<strong>market</strong>dataforecast.com/cart/buy-now/<strong>blood</strong>-<strong>group</strong>-<strong>typing</strong><strong>market</strong>-6350<br />

6.3 Europe<br />

6.2.1 Introduction<br />

6.2.2 U.K<br />

6.2.3 Spain<br />

6.2.4 Germany<br />

6.2.5 Italy<br />

6.4 Asia-Pacific<br />

6.2.6 France<br />

6.3.1 Introduction<br />

6.3.2 China<br />

6.3.3 India<br />

6.3.4 Japan<br />

6.3.5 Australia<br />

6.5 Latin America<br />

6.3.6 South Korea<br />

6.4.1 Introduction<br />

6.4.2 Brazil<br />

6.4.3 Argentina<br />

6.4.4 Mexico<br />

6.4.5 Rest of Latin America<br />

6.6 Middle East & Africa<br />

+1 888-702-9626 | www.<strong>market</strong>dataforecast.com | contact@<strong>market</strong>dataforecast.com


Global Rubella Vaccine Market<br />

6.5.1 Introduction<br />

6.5.2 Middle-East<br />

6.5.3 Africa<br />

7. Strategic Analysis<br />

7.1 PESTLE analysis<br />

7.1.1 Political<br />

7.1.2 Economic<br />

7.1.3 Social<br />

7.1.4 Technological<br />

7.1.5 Legal<br />

7.1.6 Environmental<br />

7.2 Porter’s Five analysis<br />

7.2.1 Bargaining Power of Suppliers<br />

7.2.2 Bargaining Power of Consumers<br />

7.2.3 Threat of New Entrants<br />

7.2.4 Threat of Substitute Products and Services<br />

7.2.5 Competitive Rivalry within the Industry<br />

8. Market Leaders' Analysis<br />

8.1 Bio-Rad Laboratories Inc.<br />

8.1.1 Overview<br />

8.1.2 Product Analysis<br />

8.1.3 Financial analysis<br />

8.1.4 Recent Developments<br />

8.1.5 SWOT analysis<br />

8.1.6 Analyst View<br />

8.2 Grifols S.A.<br />

8.3 Immucor Inc.<br />

8.4 Ortho Clinical Diagnostics Inc.<br />

8.5 Quotient Ltd.<br />

8.6 Novacyt Group<br />

8.7 BAG Healthcare GmbH<br />

8.8 Rapid Labs<br />

8.9 Day medical SA<br />

+1 888-702-9626 | www.<strong>market</strong>dataforecast.com | contact@<strong>market</strong>dataforecast.com


Global Rubella Vaccine Market<br />

8.10 DIAGAST<br />

9. Competitive Landscape<br />

9.1 Market share analysis<br />

9.2 Merger and Acquisition Analysis<br />

9.3 Agreements, collaborations and Joint Ventures<br />

9.4 New Product Launches<br />

10. Market Outlook and Investment Opportunities<br />

Appendix<br />

a) List of Tables<br />

b) List of Figures<br />

Check out other related reports in Healthcare<br />

Blood <strong>group</strong> <strong>typing</strong> Market : https://www.<strong>market</strong>dataforecast.com/<strong>market</strong>-reports/<strong>blood</strong>-<strong>group</strong><strong>typing</strong>-<strong>market</strong>-6350/<br />

North america <strong>blood</strong> <strong>group</strong> <strong>typing</strong> Market : https://www.<strong>market</strong>dataforecast.com/<strong>market</strong>reports/<strong>blood</strong>-<strong>group</strong>-<strong>typing</strong>-<strong>market</strong>-6352/<br />

Europe <strong>blood</strong> <strong>group</strong> <strong>typing</strong> Market: https://www.<strong>market</strong>dataforecast.com/<strong>market</strong>-reports/europe<strong>blood</strong>-<strong>group</strong>-<strong>typing</strong>-<strong>market</strong>-6354/<br />

Asia-Pacific <strong>blood</strong> <strong>group</strong> <strong>typing</strong> Market: https://www.<strong>market</strong>dataforecast.com/<strong>market</strong>reports/asia-pacific-<strong>blood</strong>-<strong>group</strong>-<strong>typing</strong>-<strong>market</strong>-6356/<br />

+1 888-702-9626 | www.<strong>market</strong>dataforecast.com | contact@<strong>market</strong>dataforecast.com


Global Rubella Vaccine Market<br />

SCOPE OF THE REPORT<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

Regional and country-level analysis and forecasts of the study <strong>market</strong>; providing<br />

Insights on the major countries/regions in which this industry is blooming and to also<br />

identify the regions that are still untapped<br />

Segment-level analysis in terms of technology, component, and type along with<br />

<strong>market</strong> size forecasts and estimations to detect key areas of industry growth in detail<br />

Identification of key drivers, restraints, opportunities, and challenges (DROC) in the<br />

<strong>market</strong> and their impact on shifting <strong>market</strong> dynamics<br />

Study of the effect of exogenous and endogenous factors that affect the global<br />

<strong>market</strong>; which includes broadly demographic, economics, and political, among other<br />

macro-environmental factors presented in an extensive PESTLE Analysis<br />

Study the micro environment factors that determine the overall profitability of an<br />

Industry, using Porter’s five forces analysis for analyzing the level of competition<br />

and business strategy development<br />

A comprehensive list of key <strong>market</strong> players along with their product portfolio,<br />

current strategic interests, key financial information, legal issues, SWOT analysis and<br />

analyst overview to study and sustain the <strong>market</strong> environment<br />

Competitive landscape analysis listing out the mergers, acquisitions, collaborations<br />

in the field along with new product launches, comparative financial studies and<br />

recent developments in the <strong>market</strong> by the major companies<br />

An executive summary, abridging the entire report in such a way that decisionmaking<br />

personnel can rapidly become acquainted with background information,<br />

concise analysis and main conclusions<br />

Expertly devised analyst overview along with Investment opportunities to provide<br />

both individuals and organizations a strong financial foothold in the markeExpertly<br />

devised analyst overview along with Investment opportunities to provide both<br />

individuals and organizations a strong financial foothold in the <strong>market</strong><br />

+1 888-702-9626 | www.<strong>market</strong>dataforecast.com | contact@<strong>market</strong>dataforecast.com


ABOUT US<br />

Market Data Forecast is a firm working in the areas of <strong>market</strong><br />

research and business intelligence. We have rich experience in<br />

research across various business domains and we cater to the needs<br />

of both individual and corporate clients. Our research services assist<br />

clients in key business areas like business process improvement, key<br />

decision making and developing appropriate corporate strategy. We<br />

are truly committed to our clients and other stakeholders for<br />

providing customized research services of the highest quality.<br />

CONTACT INFORMATION<br />

We always look forward to working with new clients, pushing our<br />

boundaries and extending our reach beyond global horizons. Get in<br />

touch with us for further queries.<br />

Website: www.<strong>market</strong>dataforecast.com<br />

E-Mail: contact@<strong>market</strong>dataforecast.com<br />

Phone: +1 888-702-9626 (U.S Toll free),<br />

+91 7680952236 (Indian Office).<br />

FOR MORE INFORMATION<br />

+1 888-702-9626 | www.<strong>market</strong>dataforecast.com | contact@<strong>market</strong>dataforecast.com

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!